Health & Wellness

Medtronic Is Notifying 3.8 Million People of a Data Breach — Here's What It Means for Patients

Medtronic, the world's largest medical device maker, is notifying 3,834,294 people that a data breach of its corporate IT systems in April 2026 may have exposed their personal and medical information, including Social Security numbers and health-related data. The data-extortion group ShinyHunters claimed responsibility. The most important thing for patients to understand up front is what was not affected: Medtronic says its devices, products and manufacturing were not touched, and the devices remain safe to use — this is a data breach, not a device-safety issue. But the exposed personal data still carries real identity-theft and phishing risk, so anyone who receives a notification letter should take the protective steps below.

11 Jul 2026 · 9 min read

Health & Wellness

The FDA Is Reviewing 7 Peptides on 23–24 July — Here's What That Does and Doesn't Mean

The FDA's Pharmacy Compounding Advisory Committee will review seven peptides — BPC-157, KPV, TB-500, MOTS-c, Emideltide (DSIP), Semax and Epitalon — on 23 and 24 July 2026, to advise on whether they should be eligible for compounding by licensed pharmacies under Section 503A. It is a distinction that is easy to miss: this is not FDA approval of these substances as safe and effective drugs, and none of them are approved for the wellness uses they are marketed for. FDA has proposed not to include any of the seven, and the more important story for consumers is about safety — specifically, the unregulated 'research chemical' market that restrictions have pushed peptide demand into.

9 Jul 2026 · 9 min read

Health & Wellness

Researchers Push Back on the FDA's 2026 Wellness-Device Guidance — What It Means for Wearable Owners

A Nature Biomedical Engineering Comment published on 23 June 2026 argues that the FDA's 2026 General Wellness guidance leaves important questions unaddressed — on validation standards, safety risks, definitional coherence and how consumer wearables fit into healthcare — as more devices show clinical-style signals like blood pressure under a 'general wellness' label. The same week, the FDA closed its 2025 warning letter to WHOOP.

2 Jul 2026 · 8 min read

Health & Wellness

Harvard Just Waded Into the Longevity Hype — and Its Main Message Is 'Do the Boring Stuff First

Harvard Health Publishing released its first-ever report dedicated to longevity science. For consumers facing a crowded market of peptide stacks, biological-age tests and subscription biomarker dashboards, the most useful thing about it is not a breakthrough — it's a trusted institution urging caution, and repeating that sleep, movement and the unglamorous basics still matter more than any supplement.

11 Jun 2026 · 6 min read

Health & Wellness

Your Fitness Tracker Wants to Be a 'Health Platform' Now — What That Means for Your Wallet and Your Data

Oura, Whoop, Garmin and others are turning rings and watches into subscription 'health platforms' built around sleep, stress and recovery scores. The insights can be genuinely useful — but they are guidance, not diagnosis, accuracy varies by metric and even by skin tone, and the real cost is the subscription, not the sticker price.

11 Jun 2026 · 7 min read

Health & Wellness

Singapore's Healthy 365 App Gets a 'Wayfinding' Feature From June 2026 — Nudging You to the Park Down the Street

From June 2026, Singapore's Health Promotion Board is adding a 'wayfinding' feature to its free Healthy 365 app to point residents toward the parks, plazas and community spaces already near them. It's a small, practical change — and it arrives just as the Apple–HPB LumiHealth programme winds down and its users move across to Healthy 365.

11 Jun 2026 · 6 min read

Health & Wellness

The FDA wants clinical trials to report in real time, with AI doing the watching

The US Food and Drug Administration has started two pilot trials that send their results to the agency as the data comes in, rather than in one big package at the end. The idea is to use AI and the cloud to shave months off a process that usually drags on for years. Done right, that means treatments reaching patients sooner.

1 Jun 2026 · 2 min read

Health & Wellness

Bayesian Health Wins First FDA Clearance for Continuous AI Sepsis Monitor, Study Shows 18% Mortality Drop

Bayesian Health's TREWS system became the first AI device cleared by the FDA to continuously monitor all hospitalised patients for sepsis — no prior clinical suspicion required. A 2022 Nature Medicine study anchoring the submission found an 18% reduction in in-hospital sepsis mortality when clinicians acted on alerts within three hours.

1 Jun 2026 · 5 min read

Health & Wellness

Commure Raises US$70M at US$7B Valuation to Deploy AI Agents Across Hospital Administration

On 19 May 2026, Commure closed a US$70 million round at a US$7 billion post-money valuation, led by General Catalyst. Its AI agents already complete more than 85% of revenue cycle work without human involvement across 500+ healthcare organisations — and the company is now pointed at international markets.

1 Jun 2026 · 5 min read

Health & Wellness

FDA Approves First Inhaled Insulin for Children: Afrezza Clears Paediatric Label After a Century of Injections

On 29 May 2026, the FDA cleared Afrezza inhaled insulin for children and adolescents aged 6 and older — the first inhaled mealtime insulin approved for paediatric use anywhere. The Phase 3 INHALE-1 trial showed no meaningful lung-function decline, though its primary HbA1c endpoint requires context: the full intent-to-treat analysis narrowly missed non-inferiority.

1 Jun 2026 · 6 min read